LSV Asset Management’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $236M | Sell |
398,665
-9,400
| -2% | -$4.68M | 0.51% | 60 |
|
|
2025
Q4 | $199M | Sell |
408,065
-278,645
| -41% | -$130M | 0.43% | 75 |
|
|
2025
Q3 | $288M | Sell |
686,710
-177,913
| -21% | -$59.8M | 0.64% | 45 |
|
|
2025
Q2 | $248M | Sell |
864,623
-37,700
| -4% | -$11.3M | 0.58% | 51 |
|
|
2025
Q1 | $278M | Sell |
902,323
-6,401
| -0.7% | -$2.19M | 0.67% | 37 |
|
|
2024
Q4 | $321M | Sell |
908,724
-60,741
| -6% | -$22.3M | 0.74% | 29 |
|
|
2024
Q3 | $347M | Buy |
969,465
+3,095
| +0.3% | +$1.05M | 0.74% | 33 |
|
|
2024
Q2 | $308M | Buy |
966,370
+436,851
| +82% | +$116M | 0.67% | 36 |
|
|
2024
Q1 | $122M | Buy |
529,519
+152,151
| +40% | +$34.3M | 0.25% | 125 |
|
|
2023
Q4 | $83M | Sell |
377,368
-5,700
| -1% | -$1.31M | 0.18% | 164 |
|
|
2023
Q3 | $86.5M | Buy |
383,068
+3,700
| +1% | +$852K | 0.2% | 153 |
|
|
2023
Q2 | $83.7M | Sell |
379,368
-18,840
| -5% | -$4.17M | 0.18% | 166 |
|
|
2023
Q1 | $89.2M | Sell |
398,208
-13,810
| -3% | -$3.4M | 0.2% | 153 |
|
|
2022
Q4 | $115M | Sell |
412,018
-153,504
| -27% | -$38.8M | 0.25% | 125 |
|
|
2022
Q3 | $118M | Sell |
565,522
-25,900
| -4% | -$5.79M | 0.28% | 115 |
|
|
2022
Q2 | $139M | Sell |
591,422
-2,980
| -0.5% | -$606K | 0.3% | 105 |
|
|
2022
Q1 | $107M | Buy |
594,402
+57,350
| +11% | +$10.9M | 0.2% | 151 |
|
|
2021
Q4 | $116M | Buy |
537,052
+12,766
| +2% | +$2.51M | 0.21% | 150 |
|
|
2021
Q3 | $96.8M | Sell |
524,286
-29,340
| -5% | -$5.78M | 0.17% | 162 |
|
|
2021
Q2 | $99.3M | Sell |
553,626
-19,770
| -3% | -$3.77M | 0.17% | 169 |
|
|
2021
Q1 | $95.9M | Sell |
573,396
-25,420
| -4% | -$4.24M | 0.16% | 170 |
|
|
2020
Q4 | $90.9M | Buy |
598,816
+40,860
| +7% | +$5.36M | 0.17% | 164 |
|
|
2020
Q3 | $56.4M | Buy |
557,956
+39,922
| +8% | +$4.38M | 0.12% | 212 |
|
|
2020
Q2 | $62.7M | Buy |
518,034
+175,287
| +51% | +$19.7M | 0.13% | 186 |
|
|
2020
Q1 | $32.5M | Buy |
342,747
+146,354
| +75% | +$13.9M | 0.08% | 248 |
|
|
2019
Q4 | $17.3M | Buy |
196,393
+67,534
| +52% | +$5.94M | 0.03% | 402 |
|
|
2019
Q3 | $10.3M | Sell |
128,859
-84,893
| -40% | -$6.84M | 0.02% | 454 |
|
|
2019
Q2 | $16.7M | Sell |
213,752
-317,463
| -60% | -$29.7M | 0.03% | 401 |
|
|
2019
Q1 | $62.3M | Sell |
531,215
-85,334
| -14% | -$9.94M | 0.1% | 213 |
|
|
2018
Q4 | $67.1M | Buy |
616,549
+106,460
| +21% | +$12.3M | 0.12% | 191 |
|
|
2018
Q3 | $65.2M | Buy |
510,089
+29,600
| +6% | +$3.66M | 0.1% | 220 |
|
|
2018
Q2 | $54.4M | Buy |
480,489
+60,149
| +14% | +$6.61M | 0.09% | 242 |
|
|
2018
Q1 | $47.2M | Buy |
420,340
+146,194
| +53% | +$18.6M | 0.08% | 250 |
|
|
2017
Q4 | $40.6M | Buy |
274,146
+102,565
| +60% | +$13M | 0.06% | 272 |
|
|
2017
Q3 | $20.1M | Sell |
171,581
-300,239
| -64% | -$38.3M | 0.03% | 372 |
|
|
2017
Q2 | $61.2M | Sell |
471,820
-791,858
| -63% | -$98.8M | 0.11% | 200 |
|
|
2017
Q1 | $171M | Sell |
1,263,678
-18,400
| -1% | -$2.79M | 0.31% | 101 |
|
|
2016
Q4 | $184M | Buy |
1,282,078
+15,418
| +1% | +$1.97M | 0.34% | 92 |
|
|
2016
Q3 | $150M | Buy |
1,266,660
+36,010
| +3% | +$4.33M | 0.29% | 104 |
|
|
2016
Q2 | $130M | Buy |
1,230,650
+50,700
| +4% | +$5.66M | 0.27% | 107 |
|
|
2016
Q1 | $131M | Buy |
1,179,950
+475,495
| +67% | +$60.2M | 0.28% | 108 |
|
|
2015
Q4 | $110M | Buy |
704,455
+600,162
| +575% | +$87.4M | 0.24% | 119 |
|
|
2015
Q3 | $13.7M | Sell |
104,293
-1,218,903
| -92% | -$195M | 0.03% | 324 |
|
|
2015
Q2 | $230M | Sell |
1,323,196
-643,540
| -33% | -$116M | 0.48% | 72 |
|
|
2015
Q1 | $339M | Sell |
1,966,736
-191,048
| -9% | -$29.1M | 0.7% | 36 |
|
|
2014
Q4 | $279M | Buy |
2,157,784
+3,996
| +0.2% | +$515K | 0.58% | 56 |
|
|
2014
Q3 | $277M | Buy |
2,153,788
+258,460
| +14% | +$26.6M | 0.61% | 49 |
|
|
2014
Q2 | $168M | Buy |
1,895,328
+150,678
| +9% | +$14.5M | 0.37% | 93 |
|
|
2014
Q1 | $164M | Sell |
1,744,650
-726,463
| -29% | -$74.3M | 0.38% | 91 |
|
|
2013
Q4 | $279M | Sell |
2,471,113
-111,348
| -4% | -$10M | 0.66% | 45 |
|
|
2013
Q3 | $204M | Sell |
2,582,461
-34,900
| -1% | -$2.55M | 0.52% | 71 |
|
|
2013
Q2 | $172M | Buy |
+2,617,361
| New | +$169M | 0.46% | 73 |
|
Other funds holding UTHR
ACA
VPM
VCM
LSV Asset Management's UTHR Position: Q1 2026 in Review
LSV Asset Management reduced its United Therapeutics (UTHR) stake by 2.3% in Q1 2026, selling an estimated $4.68M and leaving 398,665 shares worth $236M. The position accounts for 0.51% of the portfolio, ranked #60.
LSV Asset Management first reported a position in UTHR in Q2 2013 and has held it in 52 quarters since. The position peaked at $347M in Q3 2024. 850 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.
- LSV Asset Management held 398,665 shares of United Therapeutics worth $236M as of Q1 2026.
- LSV Asset Management sold 9,400 United Therapeutics shares in Q1 2026, an estimated $4.68M.
- United Therapeutics made up 0.51% of LSV Asset Management's portfolio in Q1 2026, its #60 holding.
- LSV Asset Management first reported a position in United Therapeutics in Q2 2013 and has held it in 52 quarters since.
- LSV Asset Management's United Therapeutics position peaked at $347M in Q3 2024.
- 850 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.
Based on LSV Asset Management's 13F filing for Q1 2026, filed 11 May 2026.